Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
PLEXAFORM
Third Extension - Granted
Show more
Class 5: Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Class 42: Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 21 Feb 2023Application filedNew Application Entered
- 16 Nov 2023Assigned to an examining attorneyAssigned To Examiner
- 20 Nov 2023Office action issuedNon-Final Action Written
- 17 May 2024Response to office action filedTeas Response To Office Action Received
- 23 May 2024Final refusal issuedFinal Refusal Mailed
- 4 Dec 2024Approved for publicationApproved For Pub - Principal Register
- 31 Dec 2024Published for oppositionPublished For Opposition
- 25 Feb 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 14 Aug 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 3 Feb 2026Statement-of-use extension 2 grantedSou Extension 2 Granted
- 30 Jul 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 36 events
| 2026-07-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-07-30 | Sou Teas Extension Received |
| 2026-07-30 | Sou Extension 3 Filed |
| 2026-07-30 | Sou Extension 3 Granted |
| 2026-02-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-02-03 | Sou Teas Extension Received |
| 2026-02-03 | Sou Extension 2 Filed |
| 2026-02-03 | Sou Extension 2 Granted |
| 2025-08-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-14 | Sou Teas Extension Received |
| 2025-08-14 | Sou Extension 1 Filed |
| 2025-08-14 | Sou Extension 1 Granted |
| 2025-02-25 | Noa Mailed - Sou Required From Applicant |
| 2024-12-31 | Published For Opposition |
| 2024-12-31 | Official Gazette Publication Confirmation E-Mailed |
| 2024-12-25 | Notification Of Notice Of Publication E-Mailed |
| 2024-12-04 | Approved For Pub - Principal Register |
| 2024-11-22 | Teas Request For Reconsideration Received |
| 2024-11-22 | Correspondence Received In Law Office |
| 2024-11-22 | Teas/Email Correspondence Entered |
| 2024-06-21 | Application Extension To Response Period - Received |
| 2024-06-21 | Application Extension Granted/Receipt Provided |
| 2024-05-23 | Final Refusal Mailed |
| 2024-05-23 | Final Refusal E-Mailed |
| 2024-05-23 | Notification Of Final Refusal Emailed |
| 2024-05-17 | Teas Response To Office Action Received |
| 2024-05-17 | Correspondence Received In Law Office |
| 2024-05-17 | Teas/Email Correspondence Entered |
| 2024-02-16 | Application Extension To Response Period - Received |
| 2024-02-16 | Application Extension Granted/Receipt Provided |
| 2023-11-20 | Non-Final Action Written |
| 2023-11-20 | Non-Final Action E-Mailed |
| 2023-11-20 | Notification Of Non-Final Action E-Mailed |
| 2023-11-16 | Assigned To Examiner |
| 2023-03-08 | New Application Office Supplied Data Entered |
| 2023-02-21 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Class 42 Technology & SaaS
Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 31 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.